+$8.0 million invested in T1D research in Canada in 2018
37 cutting edge projects and clinical trials supported in Canada
In 2020, the JDRF House ParT1D for a Cure raised $2.1 million to accelerate research
300,000 + Canadians live with Type 1 Diabetes (T1D)
Type 1 diabetes (T1D) affects over 300,000 Canadians. It’s an autoimmune disease where the pancreas doesn’t produce insulin, the hormone that helps the body to control glucose (sugar) levels in the bloodstream. Without insulin, glucose builds up in the blood instead of being used for energy. If left untreated, this results in significant complications and eventual death. There is no cure and people with T1D must inject themselves with artificial insulin; either by injection or pump, often several times a day.
For over 40 years, JDRF has been a global leader in the drive towards a cure for T1D, through both research funding and advocacy. JDRF also provides support to living with T1D today to live healthier, easier, and safer lives.
JDRF’s goal is to progressively diminish the impact of this disease until there is world free from T1D. Power Corporation has supported the JDRF since 1988.
JDRF’s primary priority is finding a cure for type 1 diabetes. To achieve a full reversal of T1D, the body needs a new source of glucose-responsive and insulin-producing beta cells. Regeneration of the remaining beta cells, or transplantation of an outside source of these cells are possible pathways to a cure. Two research programs are currently underway that support universal stem cell therapies.
2021 will mark the 100th anniversary of the discovery of insulin, and JDRF will be commemorating the milestone with a significant push towards accelerating research towards a cure.
Until a cure is within more immediate reach, JDRF is committed to supporting individuals and improving glucose control with drugs and devices, including the development of artificial pancreas systems. JDRF believes it is essential to find new ways to prevent, reverse or treat the complications of type 1 diabetes.
Additionally, as part of a comprehensive research program on type 1 diabetes, JDRF is funding research to better understand the underlying causes of the disease to develop screening strategies to prevent the disease from occurring in future generations.
JDRF Canada holds a variety of fundraising initiatives every year. Its Ride for Diabetes Research is held every fall and routinely attracts well over 14,500 participants from companies across the country. In 2020, the event went virtual due to COVID-19 and was still a considerable success. JDRF House ParT1D for a Cure helped raise over $2 million dollars for critical funds that support cutting-edge research and meaningful community programming.
"Corporations that support JDRF typically use it for employee engagement which furthers our profile within the general population," says Dave Prowten, President and CEO of JDRF Canada. “The commitment and passion from the business community and from companies such as Power Corporation is fundamental to helping JDRF invest more money in finding a cure for type 1 diabetes research, and at a faster pace."